[go: up one dir, main page]

EE03442B1 - Nukleosiidide analoogide diastereoselektiivne valmistamismeetod - Google Patents

Nukleosiidide analoogide diastereoselektiivne valmistamismeetod

Info

Publication number
EE03442B1
EE03442B1 EE9600134A EE9600134A EE03442B1 EE 03442 B1 EE03442 B1 EE 03442B1 EE 9600134 A EE9600134 A EE 9600134A EE 9600134 A EE9600134 A EE 9600134A EE 03442 B1 EE03442 B1 EE 03442B1
Authority
EE
Estonia
Prior art keywords
preparation
nucleoside analogues
diastereoselective method
diastereoselective
nucleoside
Prior art date
Application number
EE9600134A
Other languages
English (en)
Estonian (et)
Other versions
EE9600134A (et
Inventor
David Goodyear Michael
Owen Dwyer P.
Leithead Hill Malcolm
Jonathan Whitehead Andrew
Hornby Roy
Hallett Peter
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27267157&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE03442(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB9408103A external-priority patent/GB9408103D0/en
Priority claimed from GB9408091A external-priority patent/GB9408091D0/en
Priority claimed from GB9408112A external-priority patent/GB9408112D0/en
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of EE9600134A publication Critical patent/EE9600134A/xx
Publication of EE03442B1 publication Critical patent/EE03442B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Treatment Of Water By Oxidation Or Reduction (AREA)
EE9600134A 1994-04-23 1995-04-21 Nukleosiidide analoogide diastereoselektiivne valmistamismeetod EE03442B1 (et)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9408103A GB9408103D0 (en) 1994-04-23 1994-04-23 Chemical compounds
GB9408091A GB9408091D0 (en) 1994-04-23 1994-04-23 Process
GB9408112A GB9408112D0 (en) 1994-04-23 1994-04-23 Process
PCT/EP1995/001503 WO1995029174A1 (en) 1994-04-23 1995-04-21 Process for the diastereoselective synthesis of nucleoside analogues

Publications (2)

Publication Number Publication Date
EE9600134A EE9600134A (et) 1997-04-15
EE03442B1 true EE03442B1 (et) 2001-06-15

Family

ID=27267157

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9600134A EE03442B1 (et) 1994-04-23 1995-04-21 Nukleosiidide analoogide diastereoselektiivne valmistamismeetod

Country Status (29)

Country Link
US (2) US6051709A (is)
EP (1) EP0757684B1 (is)
JP (2) JP4056558B2 (is)
KR (1) KR100241842B1 (is)
CN (2) CN1151146C (is)
AP (1) AP704A (is)
AT (1) ATE181326T1 (is)
AU (1) AU696612B2 (is)
BG (1) BG62810B1 (is)
BR (1) BR9507499A (is)
CZ (1) CZ293827B6 (is)
DE (1) DE69510347T2 (is)
DK (1) DK0757684T3 (is)
EE (1) EE03442B1 (is)
ES (1) ES2133769T3 (is)
FI (1) FI120401B (is)
GR (1) GR3031043T3 (is)
HU (1) HU218044B (is)
IL (1) IL113432A (is)
IS (1) IS1844B (is)
NO (2) NO307179B1 (is)
NZ (1) NZ285396A (is)
PL (1) PL180090B1 (is)
RO (2) RO118714B1 (is)
RU (1) RU2158736C2 (is)
SK (1) SK281327B6 (is)
TW (1) TW487704B (is)
UA (1) UA43362C2 (is)
WO (1) WO1995029174A1 (is)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6175008B1 (en) * 1988-04-11 2001-01-16 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
IL113432A (en) * 1994-04-23 2000-11-21 Glaxo Group Ltd Process for the diastereoselective synthesis of nucleoside analogues
US6034087A (en) * 1994-10-22 2000-03-07 Chong Kun Dang Corp. Nucleoside derivatives and process for preparing thereof
GB9506644D0 (en) * 1995-03-31 1995-05-24 Wellcome Found Preparation of nucleoside analogues
US6113920A (en) * 1996-10-31 2000-09-05 Glaxo Wellcome Inc. Pharmaceutical compositions
PT2322518E (pt) * 1998-08-12 2015-06-08 Gilead Sciences Inc Métodos de fabrico de nucleosídeos de 1,3-dioxolano e 1,3 oxatiolano
GB9820417D0 (en) * 1998-09-18 1998-11-11 Glaxo Group Ltd Antiviral combinations
US6432966B2 (en) 1999-10-29 2002-08-13 Smithkline Beecham Corporation Antiviral combinations
ES2299950T3 (es) 2001-03-01 2008-06-01 Abbott Laboratories Formas polimorficas y otras formas cristalinas cis-ftc.
US6600044B2 (en) 2001-06-18 2003-07-29 Brantford Chemicals Inc. Process for recovery of the desired cis-1,3-oxathiolane nucleosides from their undesired trans-isomers
WO2003027106A1 (en) * 2001-09-25 2003-04-03 Cadila Healthcar Limited Process for the preparation of crystalline polymorph ii of lamivudine
ITMI20030578A1 (it) * 2003-03-24 2004-09-25 Clariant Lsm Italia Spa Processo ed intermedi per la preparazione di emtricitabina
US20050187913A1 (en) 2003-05-06 2005-08-25 Yoram Nelken Web-based customer service interface
CN101307048B (zh) * 2007-05-18 2011-03-23 上海迪赛诺医药发展有限公司 立体选择性制备拉米夫定的方法
US20100190982A1 (en) * 2007-09-17 2010-07-29 Janardhana Rao Vascuri Process for the preparation of lamivudine form i
EP2048151A1 (en) * 2007-10-10 2009-04-15 Cilag AG Method for producing nucleosides by direct glycosylation of the nucleoside base
CN101918393A (zh) * 2007-11-29 2010-12-15 兰贝克赛实验室有限公司 拉米夫定的晶形i及其制备方法
BRPI0820224A2 (pt) * 2007-11-29 2015-06-16 Ranbaxy Lab Ltd Composto de fórmula iii ou seus estereoisômeros; processo para sua preparação e seu uso; uso de um composto de formula iii(a) ou iii(b) em um processo para a preparação de lamivudina de fórmula i(a) ou um composto de fórmula i(c); processo para preparação de lamivudina de fórmula i(a)
BRPI0820226A2 (pt) * 2007-11-29 2015-06-16 Ranbaxy Lab Ltd Processo para o preparo de um 1,3-oxatiolana, para o preparo de lamivudina e para isolar lamivudina, lamivudina e composição farmacêutica
US8350030B2 (en) * 2007-12-07 2013-01-08 Matrix Laboratories Limited Process for producing 5-fluoro-1-(2R, 5S)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
CN101362752B (zh) * 2008-09-18 2011-12-28 浙江教育学院 一种拉米夫定中间体的合成方法
CN101391997B (zh) * 2008-09-18 2010-12-22 江苏科本医药化学有限公司 一种恩曲他滨中间体的合成方法
US20110282046A1 (en) 2009-01-19 2011-11-17 Rama Shankar Process for preparation of cis-nucleoside derivative
KR101474570B1 (ko) 2009-04-13 2014-12-19 주식회사 대희화학 라미부딘의 신규한 중간체 및 이의 제조방법
CN101544632B (zh) * 2009-04-24 2011-09-07 湖南千金湘江药业股份有限公司 拉米夫定非对映选择合成方法
ES2540074T3 (es) 2009-10-14 2015-07-08 Mylan Laboratories Limited Proceso para la preparación de lamivudina y nuevas sales en la fabricación de la misma
PH12012501537A1 (en) 2010-01-27 2018-02-07 Viiv Healthcare Co Antiviral therapy
US20120295930A1 (en) 2010-02-03 2012-11-22 Shankar Rama Novel process for the preparation of cis-nucleoside derivative
CN102167696B (zh) * 2010-02-25 2013-09-18 南京正大天晴制药有限公司 拉米夫定草酸盐及其制备方法
PL2542551T3 (pl) 2010-03-04 2015-01-30 Ranbaxy Laboratories Ltd Sposób stereoselektywnego otrzymywania 5-fluoro-1-(2R,SS)-[2-(hydroksymetylo)-1,3-oksatiolan--5-ylo]cytozyny
CN101830893A (zh) * 2010-05-31 2010-09-15 安徽一帆香料有限公司 一种拉米夫定中间体hdms的合成制备工艺
CN102399213A (zh) * 2010-09-08 2012-04-04 重庆医药工业研究院有限责任公司 拉米夫定单邻苯二甲酸盐及其合成方法
WO2012062835A1 (en) 2010-11-12 2012-05-18 Glaxo Wellcome Manufacturing Pte Ltd Novel pharmaceutical compositions
EP2697238B1 (en) 2011-04-08 2019-03-20 Laurus Labs Limited Solid forms of antiretroviral compounds, process for the preparation and their pharmaceutical composition thereof
CN102796088B (zh) * 2012-05-21 2015-06-10 湖南千金湘江药业股份有限公司 一种拉米夫定的制备方法
CN103450166A (zh) * 2012-05-31 2013-12-18 上海迪赛诺药业有限公司 制备核苷化合物的方法
CN103864835A (zh) * 2013-03-26 2014-06-18 安徽贝克联合制药有限公司 一种提高拉米夫定中间体立体选择性制备方法
CN103288806A (zh) * 2013-07-02 2013-09-11 山东大学 一种曲沙他滨的合成方法
CN103694231A (zh) * 2013-11-28 2014-04-02 安徽一帆香料有限公司 一种拉米夫定中间体hdms的合成制备方法
US9571109B2 (en) * 2015-03-27 2017-02-14 International Business Machines Corporation Voltage controlled oscillator runaway prevention
CN106146481A (zh) * 2015-04-07 2016-11-23 江苏普信制药有限公司 一种核苷类似物的制备方法
CN105037340B (zh) * 2015-07-14 2018-08-10 福建广生堂药业股份有限公司 一种拉米夫定关键中间体手性异构体杂质的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466806A (en) * 1989-02-08 1995-11-14 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US6175008B1 (en) * 1988-04-11 2001-01-16 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
AU3154993A (en) * 1989-02-08 1994-07-19 Biochem Pharma Inc. Process for preparing substituted 1,3-oxathiolanes with antiviral properties
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
US5587480A (en) * 1990-11-13 1996-12-24 Biochem Pharma, Inc. Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
AU1787492A (en) 1991-05-16 1992-12-30 Glaxo Group Limited Antiviral combinations containing nucleoside analogs
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
ZA923641B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9116601D0 (en) * 1991-08-01 1991-09-18 Iaf Biochem Int 1,3-oxathiolane nucleoside analogues
IL113432A (en) * 1994-04-23 2000-11-21 Glaxo Group Ltd Process for the diastereoselective synthesis of nucleoside analogues

Also Published As

Publication number Publication date
JPH10502615A (ja) 1998-03-10
AP704A (en) 1998-12-04
CZ309696A3 (en) 1997-04-16
JP2007217425A (ja) 2007-08-30
IS4366A (is) 1996-09-27
US6051709A (en) 2000-04-18
EE9600134A (et) 1997-04-15
CN1151146C (zh) 2004-05-26
AP9600871A0 (en) 1996-10-31
BG62810B1 (bg) 2000-08-31
EP0757684A1 (en) 1997-02-12
ATE181326T1 (de) 1999-07-15
SK281327B6 (sk) 2001-02-12
PL180090B1 (pl) 2000-12-29
EP0757684B1 (en) 1999-06-16
IL113432A0 (en) 1995-07-31
FI964251L (fi) 1996-10-22
FI964251A0 (fi) 1996-10-22
JP4056558B2 (ja) 2008-03-05
HK1004221A1 (en) 1998-11-20
PL316904A1 (en) 1997-02-17
DE69510347D1 (de) 1999-07-22
SK135596A3 (en) 1997-07-09
DE69510347T2 (de) 1999-11-18
BR9507499A (pt) 1997-09-23
RU2158736C2 (ru) 2000-11-10
NO307179B1 (no) 2000-02-21
AU2447195A (en) 1995-11-16
HU218044B (hu) 2000-05-28
CN1290841C (zh) 2006-12-20
CZ293827B6 (cs) 2004-08-18
IL113432A (en) 2000-11-21
KR100241842B1 (ko) 2000-03-02
NO964487L (no) 1996-12-17
NO995646D0 (no) 1999-11-17
UA43362C2 (uk) 2001-12-17
HU9602925D0 (en) 1996-12-30
DK0757684T3 (da) 2000-01-17
IS1844B (is) 2003-01-30
NO995646L (no) 1999-11-17
CN1149871A (zh) 1997-05-14
HUT76296A (en) 1997-07-28
BG100916A (en) 1997-07-31
WO1995029174A1 (en) 1995-11-02
AU696612B2 (en) 1998-09-17
US6329522B1 (en) 2001-12-11
CN1500782A (zh) 2004-06-02
NZ285396A (en) 1998-10-28
ES2133769T3 (es) 1999-09-16
TW487704B (en) 2002-05-21
RO117916B1 (ro) 2002-09-30
NO313096B1 (no) 2002-08-12
NO964487D0 (no) 1996-10-22
RO118714B1 (ro) 2003-09-30
GR3031043T3 (en) 1999-12-31
FI120401B (fi) 2009-10-15

Similar Documents

Publication Publication Date Title
EE9600134A (et) Nukleosiidide analoogide diastereoselektiivne valmistamismeetod
EE200000155A (et) Taksoidide klassi kuuluvate derivaatide valmistamismeetod
FI973281L (fi) Menetelmä tiettyjen atsasykloheksapeptidien valmistamiseksi
FI945441A7 (fi) Uusi menetelmä 7beta-substituoitu-4-atsa-5alfa-androstan-3-onien valmi stamiseksi
FI965268A0 (fi) Menetelmä moniarvoisten alkoholien valmistamiseksi
IT1315269B1 (it) Metodo per la preparazione di 5-cianoftalide
FI951903L (fi) Menetelmä gingkolidi B:n valmistamiseksi ginkgolidi C:stä
FI972065A0 (fi) Menetelmä N-fosfonometyyliglysiinin valmistamiseksi
IT1269916B (it) Procedimento migliorato per la sintesi di dimetilcarbonato
TR199800403A3 (tr) a-Bromo-laktam türevlerinin hazirlanmasi için yöntem.
FI964410A7 (fi) Menetelmä 4-amino-delta4-3-ketosteroidien valmistamiseksi 4-nitro-delt a4-3-ketosteroidien kautta
EE9900404A (et) Arüülaminotriasolopüridiinide valmistamise meetod
FI971964L (fi) Menetelmä 1-halo-3-trialkyylisilasnyylibentseenijohdannaisten valmistamiseksi
FI955110L (fi) Menetelmä massan sakeuden lisäämiseksi
FI953181A0 (fi) Puriinien valmistusmenetelmä
NO20003077L (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
FI951441A7 (fi) Menetelmä 5-formyyliamino-pyrimidiinien valmistamiseksi
NO20002476D0 (no) FremgangsmÕte for fremstilling av formylimidazoler
UA25571A (uk) Спосіб приготуваhhя кормової домішки
EE9600007A (et) Diltiaseemi valmistamise meetod
IT1275450B (it) Procedimento per la preparazione di beta-idrossiidroperossidi
ZA953235B (en) Process for the diastereoselective synthesis of nucleoside analogues
SI0757684T1 (en) Process for the diastereoselective synthesis of nucleoside analogues
LV10947A (lv) Piroglutaminskabes 4-metilkumaril-7-amida iegusanas metode
ITMI940613A0 (it) Procedimento per la preparazione di 17-idrossi-1-alfa, 2-alfa -metilenepregna-4, 6-dien-3,20-dione

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231